Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Traditional Chinese medicine in COVID-19
Ming Lyu, Guanwei Fan, Guangxu Xiao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3337-3363
Open Access | Times Cited: 182

Showing 1-25 of 182 citing articles:

The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19
Qing Hu, Yuan Xiong, Guanghao Zhu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 148
Post-COVID-19 fatigue: A systematic review
Jian Joli, Patrizia Buck, Stephan Zipfel, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 114
Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19
Haiyu Xu, Shufen Li, Jiayuan Liu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 18
Open Access | Times Cited: 81
Xuanfei Baidu formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-κB and MAPK pathways in LPS-induced ALI and inflammation models
Zhenhao Li, Haitao Pan, Jihong Yang, et al.
Phytomedicine (2022) Vol. 108, pp. 154545-154545
Open Access | Times Cited: 78
Introduction to Traditional Medicine and Their Role in Prevention and Treatment of Emerging and Re-Emerging Diseases
Syed A. A. Rizvi, George P Einstein, Orien L. Tulp, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1442-1442
Open Access | Times Cited: 72
The Gut–Organ-Axis Concept: Advances the Application of Gut-on-Chip Technology
Yuxi Guo, Xuefeng Chen, Pin Gong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4089-4089
Open Access | Times Cited: 55
Bioactive natural products in COVID-19 therapy
Zhonglei Wang, Ning Wang, Liyan Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 58
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 48
Traditional Chinese medicine against COVID-19: Role of the gut microbiota
Zhihua Yang, Yangxi Liu, Lin Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112787-112787
Open Access | Times Cited: 45
QSAR-based virtual screening of traditional Chinese medicine for the identification of mitotic kinesin Eg5 inhibitors
Damilola S. Bodun, Damilola A. Omoboyowa, Olaposi Idowu Omotuyi, et al.
Computational Biology and Chemistry (2023) Vol. 104, pp. 107865-107865
Closed Access | Times Cited: 26
Similar but Different Three Major Traditional Medicines in East Asia: A Bibliometric Analysis
Chan‐Young Kwon
Chinese Journal of Integrative Medicine (2025)
Closed Access | Times Cited: 1
Qingjin Yiqi granules for post‐COVID‐19 condition: A randomized clinical trial
Wentai Pang, Fengwen Yang, Yubin Zhao, et al.
Journal of Evidence-Based Medicine (2022) Vol. 15, Iss. 1, pp. 30-38
Open Access | Times Cited: 32
Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand
Karim Farmanpour-Kalalagh, Arman Beyraghdar Kashkooli, Alireza Babaei, et al.
Frontiers in Plant Science (2022) Vol. 13
Open Access | Times Cited: 31
In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
Md. Mominur Rahman, Md. Rezaul Islam, Shopnil Akash, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 31
Epigenetic Regulation in the Pathogenesis of Rheumatoid Arthritis
Chao Yang, Dan Li, Dehong Teng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
TCM2COVID: A resource of anti‐COVID‐19 traditional Chinese medicine with effects and mechanisms
Liping Ren, Yi Xu, Lin Ning, et al.
iMeta (2022) Vol. 1, Iss. 4
Open Access | Times Cited: 29
Version updates of strategies for drug discovery based on effective constituents of traditional Chinese medicine
Nan Ge, Guangli Yan, Hui Sun, et al.
Acupuncture and Herbal Medicine (2023) Vol. 3, Iss. 3, pp. 158-179
Open Access | Times Cited: 21
Formation of a traditional Chinese medicine self-assembly nanostrategy and its application in cancer: a promising treatment
Ju Huang, Yu Zhu, Hang Xiao, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 20
Multi-ligand molecular docking, simulation, free energy calculations and wavelet analysis of the synergistic effects between natural compounds baicalein and cubebin for the inhibition of the main protease of SARS-CoV-2
Hong Li, Akari Komori, Mingdi Li, et al.
Journal of Molecular Liquids (2023) Vol. 374, pp. 121253-121253
Open Access | Times Cited: 18
Herb pairs containing Curcumae Rhizoma (Ezhu): A review of bio-active constituents, compatibility effects and t-copula function analysis
Li-Ting Lin, Xiaomei Zhou, Tianhui Gao, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117199-117199
Closed Access | Times Cited: 18
Baicalin inhibits PANoptosis by blocking mitochondrial Z-DNA formation and ZBP1-PANoptosome assembly in macrophages
Yi-Ping You, Yan Liang, Hua-yu Ke, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 8
Research progress on antidepressant effects and mechanisms of berberine
Yang Gao, Kexin Nie, Hongzhan Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Structure-Based Discovery of the SARS-CoV-2 Main Protease Noncovalent Inhibitors from Traditional Chinese Medicine
Xiaojie Jin, Min Zhang, Beibei Fu, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 4, pp. 1319-1330
Closed Access | Times Cited: 7
Inhibitory Efficacy of Main Components of Scutellaria baicalensis on the Interaction between Spike Protein of SARS-CoV-2 and Human Angiotensin-Converting Enzyme II
Cheng‐Han Lin, Ho-Ju Chang, M. C. Lin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2935-2935
Open Access | Times Cited: 7
The safety of Chinese medicine: A systematic review of endogenous substances and exogenous residues
Wenyue Chen, Hua Luo, Zhangfeng Zhong, et al.
Phytomedicine (2022) Vol. 108, pp. 154534-154534
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top